Mesothelioma Cancer Resources Blog

The mesothelioma community closely watches for any study that results in a better quality of life or extended survival for mesothelioma patients. With no cure and limited survival, mesothelioma is challenging to treat and patients are faced with a grim prognosis. Now, researchers in Japan report that the chemotherapy drug Alimta, when used as maintenance …

A drug developed to treat bile duct cancer, a rare disease that strikes 2,000 – 3,000 Americans each year, will be closely watched by the mesothelioma community as it enters Phase 3 trials in several countries, including the U.S. Phase 3 trials enroll more patient volunteers than in Phase 2, where an experimental drug is …

Mesothelioma patients will soon have access to a new treatment through a clinical trial thanks to a recent discovery by Australian researchers. The researchers found a way to shut down a tumor’s “life support system” by using an antibody to attack the protein Epha3. A team of researchers from Australia found that by targeting Epha3, …